NCT03886701 · Interventional trial
Doravirine, Rifapentine and Isoniazid Interaction
Overall registry status Completed
Phase 1
Conditions Drug Interaction Potentiation, Human Immunodeficiency Virus, Latent Tuberculosis, Rifamycins Causing Adverse Effects in Therapeutic Use
Delaware Valley sites
- Thomas Jefferson University Clinical Research Unit · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory